Havens Advisors’s Amgen AMGN Stock Holding History

Havens Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,000	Closed	-$746K	–	22
2017 Q3	$746K	Hold	4,000	–	–	0.5%	25
2017 Q2	$689K	Hold	4,000	–	–	0.49%	28
2017 Q1	$656K	Hold	4,000	–	–	0.43%	28
2016 Q4	$585K	Sell	4,000 -7,276	-65%	-$1.1M	0.39%	34
2016 Q3	$1.88M	Hold	11,276	–	–	1.47%	21
2016 Q2	$1.72M	Hold	11,276	–	–	1.3%	26
2016 Q1	$1.69M	Hold	11,276	–	–	0.86%	31
2015 Q4	$1.83M	Hold	11,276	–	–	1.11%	31
2015 Q3	$1.56M	Hold	11,276	–	–	0.95%	22
2015 Q2	$1.73M	Hold	11,276	–	–	1.29%	24
2015 Q1	$1.78M	Hold	11,276	–	–	1.42%	23
2014 Q4	$1.8M	Hold	11,276	–	–	1.11%	32
2014 Q3	$1.58M	Hold	11,276	–	–	0.88%	42
2014 Q2	$1.33M	Hold	11,276	–	–	0.97%	34
2014 Q1	$1.26M	Hold	11,276	–	–	1.28%	24
2013 Q4	$1.29M	Hold	11,276	–	–	1.02%	33
2013 Q3	$1.26M	Hold	11,276	–	–	0.7%	41
2013 Q2	$1.11M	Buy	+11,276	New	+$1.17M	0.87%	36

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Havens Advisors's AMGN Position: Q4 2017 in Review

Havens Advisors sold out of Amgen (AMGN) in Q4 2017, closing a stake of 4,000 shares — an estimated $746K sold.

Havens Advisors first reported a position in AMGN in Q2 2013 and held it in 18 quarters. The position peaked at $1.88M in Q3 2016. 1,734 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

Havens Advisors reported no remaining Amgen position as of Q4 2017 after selling out during the quarter.
Havens Advisors sold 4,000 Amgen shares in Q4 2017, an estimated $746K.
Havens Advisors first reported a position in Amgen in Q2 2013 and held it in 18 quarters.
Havens Advisors's Amgen position peaked at $1.88M in Q3 2016.
1,734 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on Havens Advisors's 13F filing for Q4 2017, filed 17 Jan 2018.